Research Associate in Cancer Cell Signalling and Drug Target Validation

This 18-month fixed-term Research Associate position is part of the Newcastle CRUK Drug Discovery Group, focusing on validating emerging drug targets in squamous cancers. The role involves designing and deploying genetic and pharmacological strategies (e.g., RNAi, CRISPR, degron systems) in human tumour cell models to generate biological evidence supporting novel therapeutic strategies. The post holder will collaborate with academic and industry experts, analyse molecular and cellular responses, and contribute to translational drug discovery decision-making. Candidates should have a strong background in cancer cell signalling, modern genetic manipulation techniques, and experience in multidisciplinary research environments. A PhD in cell biology or a related discipline is required.